Subscribe To
Coherus biosciences' q4 sales fall 34% on lower udenyca volume, prices
Coherus BioSciences Inc's (NASDAQ: Chrs) Q4 net revenue was $73.4 million for Q4 FY21 compared to $1...
February 18, 2022, 5:51 am
Coherus biosciences, inc. (chrs) ceo denny lanfear on q4 2021 results - earnings call transcript
Coherus BioSciences, Inc. (Chrs) CEO Denny Lanfear on Q4 2021 Results - Earnings Call Transcript...
February 17, 2022, 11:10 pm
Coherus biosciences, inc. (chrs) ceo denny lanfear on q4 2021 results - earnings call transcript
Coherus BioSciences, Inc. (Chrs) CEO Denny Lanfear on Q4 2021 Results - Earnings Call Transcript...
February 17, 2022, 11:10 pm
Coherus biosciences, inc. (chrs) ceo denny lanfear on q4 2021 results - earnings call transcript
Coherus BioSciences, Inc. (Chrs) CEO Denny Lanfear on Q4 2021 Results - Earnings Call Transcript...
February 17, 2022, 11:10 pm